Bladder Tone Spray
NDC Package 50845-0271-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bladder Tone (belladonna, cantharis, causticum, cina, equisetum hyemale, ignatia amara, physalis alkekengi, pulsatilla (pratensis), sepia, verbascum thapsus) sprays May temporarily relieve symptoms associated with abnormal bladder function.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a spray delivery system. Marketed by Liddell Laboratories, Inc., this product is identified by NDC 50845-0271.

Identification & Billing

NDC Package Code
50845-0271-1
Package Description
30 mL in 1 BOTTLE, SPRAY
Product Code
50845-0271
11-Digit Billing Format
50845027101

Clinical Specifications

Proprietary Name
Bladder Tone
Non-Proprietary Name
Belladonna, Cantharis, Causticum, Cina, Equisetum Hyemale, Ignatia Amara, Physalis Alkekengi, Pulsatilla (pratensis), Sepia, Verbascum Thapsus
Substance Name
Artemisia Cina Pre-flowering Top; Atropa Belladonna; Causticum; Equisetum Hyemale Whole; Lytta Vesicatoria; Physalis Alkekengi Fruit; Pulsatilla Pratensis Whole; Sepia Officinalis Juice; Strychnos Ignatii Seed; Verbascum Thapsus Whole
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
May temporarily relieve symptoms associated with abnormal bladder function.****Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. May temporarily relieve symptoms associated with abnormal bladder function.****Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Regulatory & Marketing

Labeler Name
Liddell Laboratories, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-28-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50845-0271-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Bladder Tone, a human over the counter drug labeled by Liddell Laboratories, Inc.. This spray is formulated for oral use and contains artemisia cina pre-flowering top; atropa belladonna; causticum; equisetum hyemale whole; lytta vesicatoria; physalis alkekengi fruit; pulsatilla pratensis whole; sepia officinalis juice; strychnos ignatii seed; verbascum thapsus whole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Liddell Laboratories, Inc. on September 28, 2020. The current certification is valid through December 31, 2026.

How is this Liddell Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50845027101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50845-0271-1
11-Digit CMS (5-4-2)
50845-0271-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.